Project information
National institute for cancer research (NÚVR)

Project Identification

LX22NPO5102

Project Period

6/2022 - 12/2025

Investor / Pogramme / Project type

Ministry of Education, Youth and Sports of the CR

national recovery plan
5.1 EXCELES

MU Faculty or unit

Faculty of Medicine

Other MU Faculty/Unit

Faculty of Science

Other MU Faculty/Unit

Central European Institute of Technology

Keywords

oncology, cancer, national institute

Cooperating Organization

Institute of Microbiology of the ASCR, v. v. i.

Responsible person Ing. Jiří Hašek, CSc.

Institute of Experimental Medicine of the ASCR, v. v. i.

Responsible person Ing. Miroslava Anděrová, CSc.

Institute of Macromolecular Chemistry of the ASCR, v. v. i.

Responsible person Dr. Ing. Jiří Kotek

Institute of Molecular Genetics of the ASCR, v. v. i.

Responsible person RNDr. Petr Dráber, DrSc.

Institute of Organic Chemistry and Biochemistry of the ASCR, v. v. i.

Responsible person prof. RNDr. Jan Konvalinka, CSc.

Institute of Photonics and Electronics of the ASCR, v. v. i.

Responsible person doc. Ing. Pavel Peterka, Ph.D.

Charles University

Responsible person prof. MUDr. Alexi Šedo, DrSc.

Palacký University, Olomouc

Responsible person prof. MUDr. Martin Procházka, Ph.D.

Masaryk Memorial Cancer Institute Brno

Responsible person prof. MUDr. Marek Svoboda, Ph.D.

The aim of the project is to create a nationwide network of collaborating workplaces conducting cutting-edge research in the field of oncology, which will take the form of a "National Institute". The reason for the creation of this authority is that research in oncology is currently not coordinated in any way and is fragmented across institutions.
The establishment of a National Institute for Cancer Research will bring together cutting-edge scientific expertise, tertiary education and relevant medical/health information resources. The thematic complementarity of the individual departments within the National Cancer Research Institute will allow for a comprehensive approach necessary for modern cancer research, concentrating on priority areas of medical education and research in the Czech Republic. Cancer research will thus become much more coordinated, strategic and efficient.
The great advantage of the National Institute is its transformative character, i.e. no new infrastructure will be built (an exception is the necessary construction of the GMP for somatic cell and gene therapy ATMP in pavilion C03), but the development and modernisation of existing capacities and human resources. This approach is highly efficient and financially sustainable in the long term.
The network of collaborating sites will consist of three Nodes (Prague Node - coordinator, Brno Node, Olomouc Node), which will cover the whole Czech Republic. The individual Nodes will be connected through a consortium agreement that defines the frameworks and rules of cooperation.

Sustainable Development Goals

Masaryk University is committed to the UN Sustainable Development Goals, which aim to improve the conditions and quality of life on our planet by 2030.